Obesity
Studies from Italy, France and the United States advance knowledge in obesity research
Published in Obesity and Diabetes Week, May 22nd, 2006
Study 1: Botulinum toxin A reduces appetite and may be a potential obesity treatment.
According to a study from Italy, "A potential approach to the treatment of morbid obesity is reduction of gastric emptying to achieve satiety. Botulinum toxin A (Btx-A) is a long-acting inhibitor of acetylcholine-mediated peristalsis, which is mainly responsible for gastric motility."
D. Gui and colleagues working with Universita Cattolica del Sacro Cuore proposed, "To investigate whether botulinum toxin A, injected in the antrum of obese patients, delays...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Genetics & Genomics
Anthocyanins can regulate adipocytokine gene expression in obesity and diabetes - Obesity
BNP and N-terminal pro-BNP linked to gastric bypass surgery history in obese patients - Obesity
Cytokines promote Wnt signaling and inflammation in 3T3-L1 preadipocytes - Obesity Complications
Waist-to-hip ratio is important marker of endothelial dysfunction across wide BMI range - Obesity Therapy
Angiotensin AT1 receptor blockage improves renal function survival of obese Zucker rats - Anesthesia
Supraclavicular block success rate linked to obesity - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
